Can Children Take Antibiotics?
Yes, children can and should take antibiotics when there is a confirmed or highly suspected bacterial infection, but antibiotics should NOT be prescribed for viral infections or when bacterial infection is unlikely. The decision must be based on specific clinical criteria that distinguish bacterial from viral illness.
Determining When Antibiotics Are Appropriate
The fundamental principle is to determine the likelihood of a bacterial infection before prescribing 1. Many pediatric upper respiratory infections are viral and do not benefit from antibiotics, while inappropriate use increases adverse events and antibiotic resistance 2, 3.
For Specific Conditions:
Community-Acquired Pneumonia (CAP):
- Children under 5 years: Oral amoxicillin 90 mg/kg/day in 2 doses is first-line for presumed bacterial pneumonia 4, 5
- Children 5 years and older: Oral amoxicillin 90 mg/kg/day (maximum 4 g/day); add a macrolide if atypical bacteria cannot be ruled out 4
- Hospitalized children (fully immunized): IV ampicillin or penicillin G; alternatives include ceftriaxone or cefotaxime 4
- Treatment duration: 10 days for pneumococcal pneumonia, at least 14 days for atypical pneumonia 6
Acute Otitis Media (AOM):
- Requires strict diagnostic criteria: moderate/severe bulging of tympanic membrane OR otorrhea OR mild bulging with ear pain 1
- First-line: Amoxicillin with or without clavulanate 1
- Consider watchful waiting in select older patients with non-severe disease 1
Acute Bacterial Sinusitis:
- Only treat if symptoms are worsening, severe, or persistent >10 days without improvement 1
- First-line: Amoxicillin with or without clavulanate 1
Pharyngitis:
- Must confirm Group A Streptococcus with rapid testing or culture before treating 1
- Do NOT treat empirically
- First-line: Amoxicillin or penicillin 1
Severe Bacterial Infections (Sepsis, Meningitis):
- Infant sepsis/meningitis: Ampicillin IV 50 mg/kg QDS plus gentamicin IV 5-7.5 mg/kg daily 7
- Older child sepsis: Ampicillin IV 50 mg/kg QDS plus gentamicin IV 7.5 mg/kg daily, OR ceftriaxone IV 50 mg/kg daily 7
- Meningitis: Ceftriaxone IV 50 mg/kg BD for 7-10 days OR cefotaxime IV 50 mg/kg QDS 7
Critical Considerations
Weighing Benefits vs. Harms
Benefits are limited to confirmed bacterial infections 1:
- For strictly defined AOM: Number needed to treat (NNT) as few as 4 patients for symptom improvement
- For confirmed Group A Strep pharyngitis: Shortens symptoms, prevents rheumatic fever
- For bacterial sinusitis: Improves symptoms at 3 and 14 days
Harms occur with unnecessary use 1, 2:
- Increased risk of diarrhea, dermatitis, C. difficile colitis
- Selection of antibiotic-resistant bacteria
- Adverse events requiring medical attention
- In one study, 30% of hospitalized children with COVID-19 received antibiotics despite only 7% having confirmed bacterial infection 2
Common Pitfalls to Avoid
Do NOT prescribe antibiotics for:
Avoid broad-spectrum antibiotics when narrow-spectrum agents are appropriate - this reduces selection pressure for resistance 7
Do NOT use empiric therapy for pharyngitis - always confirm with testing 1
Reassess at 48-72 hours - if no improvement, consider alternative diagnosis or atypical bacteria 4, 6
Resource-Limited Settings
In resource-poor settings, the WHO Pocket Book recommends a limited formulary of 8 major antibiotics for severe bacterial infections 7. Weight-based dosing is essential, and when scales are unavailable, alternative methods like the Broselow or Mercy TAPE can estimate weight 7.
Duration of Therapy
Shorter courses are often adequate 10:
- Non-severe pneumonia: 3-5 days shows no difference in cure rates compared to longer courses
- Most conditions: 5-7 days is sufficient with appropriate de-escalation 10
The bottom line: Antibiotics are essential, life-saving medications for children with bacterial infections, but they should be reserved for situations where bacterial infection is confirmed or highly likely based on specific clinical criteria. Judicious use protects both the individual child from adverse effects and the broader community from antibiotic resistance.